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Summary
Activin A/erythroid differentiation factor (EDF), a dimeric polypeptide hormone composed of
two OA subunits, regulates growth and erythroid differentiation of human hematopoietic
progenitor and erythroleukemia cells. We have identified activated human peripheral blood
monocytes as a natural source of activin A/EDF. In these cells, lipopolysaccharide (LPS) induced
rapidly the expression of the OA subunit mRNAs through protein kinase C-dependent
transcriptional regulation . The /3A subunit mRNA expression was also increased by 1,25-
dihydroxyvitamin D3, an inducer of macrophage maturation of monocytes . Western analysis
with an anti-(3A antibody and an erythroid differentiation bioassay confirmed that the
conditioned media of LPS-activatedmonocytes contained the activinA/EDFprotein . We suggest
that monocyte/macrophage-derived activin A/EDF may not only modulate hematopoietis but
may also act as amediator molecule in the diverse physiologic and pathogenetic events in which
these cells are involved .
Erythroid differentiation factor (EDF) is apolypeptide that
exhibits potent differentiation-inducing activity toward
cultured erythroleukemia cells (1, 2) and enhances the growth
of normal erythroid precursor cells both in vitro (2, 3) and
in vivo (4) . This protein, composed of two identical cova-
lently linked 14-kD subunits, wasoriginally found in the cul-
ture fluid of human leukemia THP-1 cell line (1) . Further
characterization by cDNA cloning and sequencing revealed
that EDF is encoded by the same mRNA as that of the RA
subunit of inhibin A and activin A, gonadal hormones that
suppress and enhance, respectively, the secretion of pituitary
follicle-stimulating hormone (5, 6) . Inhibins consist of an
a subunit, and one of the two a subunits (OA or RB) and
activins are homo- or heterodimers of the (3 subunits (6) .
Although inhibin subunit gene expression occurs in rat
bone marrow and spleen (7), the natural cellular source of
activin or inhibin in the hematopoietic system has remained
obscure. Activin A/EDF has been shown to be expressed in
several human myeloid leukemia cell lines (1, 8), but no data
on its production by normal myeloid cells have been reported .
We now show that activated human peripheral bloodmono-
cytes express the OA subunit mRNA and secrete the im-
munoreactive and bioactive activin A/EDF protein .
Cell Cultures.
￿
Human peripheral blood monocytes were iso-
lated from leukocyte-rich buffy coats obtained from the Finnish
Red Cross Blood Transfusion Service (Helsinki, Finland) by cen-
trifugation on Ficoll-Isopaque (Pharmacia, Uppsala, Sweden) and
1-h adherence to plastic dishes, and were cultured in RPMI 1640
containing 10% heat-inactivated humanAB serum(from the same
source as buffy coats), 10mM Hepes, 2mM glutamine, and antibi-
otics . About 90%of the adherent cells were monocytes, as demon-
stratedby standard morphological criteria or monocyte-specific an-
tibodies (data not shown) . The cells were stimulated with PMA
(Sigma Chemical Co., St . Louis, MO), LPS (Escherichia coli 026:B6 ;
Difco Laboratories, Detroit, MI), and VD3 (Hoffman-La Roche,
Inc., Nutley, NJ), or treated with protein kinase inhibitors HA1004
and H7 (Seigaku America, Inc., St . Petersburg, FL) for indicated
time periods . All experiments were repeated at least twice .
RNA Analyses. Total RNA was isolated by guanidine
isothiocyanate/CsCl, and 30 jcg of RNAs was run in 1.2%
formaldehyde-agarose gels, and transferred on nylon membranes
according to standard methods (9) . In vitro transcribed [3zP]UTP-
labeled antisense cRNA probes from full-length human inhibin
tx, and (3A and (3H subunit cDNA templates (10) in pGEM-4Z
plasmids (Promega-Biotec, Madison, WI) were hybridized to the
filtersand high-stringency washes performed as previously described
(11) . As a control forRNAloading, filters were hybridized to human
(3-actin cDNA probe, which showed no substantial variation of
RNA amounts between different lanes (not shown) . For nuclear
run-off transcription assay, nuclei were isolated from 2 x 107
monocytes induced for 4hwithPMAand used for a 20-min tran-
scription reaction according to Greenberg and Ziff (12) . Slot blots
with 2 p,g of each plasmid were hybridized to 2 .0 x 106 cpm/ml
of "P-labeled nuclear RNAs for 48 h, washed, and RNase A
treated as previously described (12) . Reverse-transcription (RT)-
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essentially as described by Rappolee et al . (13) . 40 95°C (30s)-54°C
(30s)-72°C (90 s) PCR cycles were performed in a 50-/Al vol with
primers 5'-GTTTGCCGAGTCAGGAACAG-3' and 5'-GAGGTT
GGCAAAGGGGCTATGGCCCCGCAT3' for human OA subunit
(10), and5'-CCCAGGCACCAGGGCGTGAT3' and5'-TCAAA-
CATGATCTGGGTCAT3' forhuman (3-actin (14) . The monoryte
RAPCRproduct was subdoned into pCR1000 vector (InVitrogen,
San Diego, CA)and its sequence determined by the dideoxymethod.
Western Analysis.
￿
For production of anti -NA Abs, the synthetic
peptide Cys-Gly-Gly-(OA 93-105) was coupled to KLH (custom
peptide synthesis and coupling by Multiple Peptide Systems, San
Diego, CA) andthe conjugatewas used to immunize rabbits with
400 Pg of the Ag first in CFA and then in IFA at 6-wk intervals .
ForWestern analysis of monocyte-secreted activin-A/EDF, culture
media (containing 1% AB serum) conditioned for 48 h with un-
stimulated or LPS-stimulated cells (cells cultured at 106/ml) were
concentrated with the useofCentricon 10 (Amicon, Beverly, MA) .
Duplicate 30-P,1 aliquots equivalent to 500 P1 of medium (-180
lug of total proteins) were run on reducing SDS-PAGE and trans-
ferred to nitrocellulose. Blots were incubated overnight at4°Cwith
a 1 :2,000 dilution of the rabbit no . 560 antiOA(93-105) antipep-




1-ml test samples of monocyte-con-
ditioned media were concentrated to 60 fA as above and divided
into 30-iAl heat-treated (5 min at 95°C) and nontreated aliquots .
10 /Al of test samples and their threefold serial dilutions was added
in duplicate to 10" target K562 cells in 90 Al RPMI 1640-10%
FCS . Dilutions of recombinanthuman (rh)-activin A/EDF (0.1-100
ng/ml) were used as positive controls. Cells were cultured for
4d at 37°C, and thereafter, hemoglobin-positive cells were stained
with benzidine (15) and scored under microscope.
Results and Discussion
Human peripheral blood monorytes did not spontaneously
express any of the inhibin subunit mRNAs in our culture
conditions, which are strictly free of LPS . By contrast, in
RNA from monocytes activated 4 h with LPS, our OA
subunit cRNA probe detected transcripts of molecular size
similar to those previously described in other human tissues
(8, 16). PMA, a regulator of protein kinase C (17), mim-
icked the effect of LPS on aAmRNA expression (Fig. 1 A) .
VD3, which induces macrophage maturation of monocytes
(18), also induced (3A subunit mRNA expression at 24 h
after stimulation but not yet at 4 h (Fig . 1 A) . Theinduction
of (3AmRNA with LPS was rapid and transient, as the ex-
pression level declined in 24-h samples as compared with those
at 4 h (Fig . 1 A) . At 24 h, PMA-induced OA mRNA ex-
pression was about the same as at 4 h (Fig . 1 A) . The effect
of LPS on /3A mRNAs was inhibited by H7, a potent in-
hibitor of both protein kinasesA andC, but notby HA1004,
which preferentially inhibits A-kinase with only a weak effect
on C-kinase (19) . This suggests that LPS mediates its effect
on monoryte OAmRNA expression through the protein ki-
nase C-dependent signaling pathway. Nuclear run-off assay
with human monorytes showed that PMA activates directly
(3A subunit gene transcription within 4 h (Fig. 1 B) . RT




Northern analysis, nuclear run-off transcription assay, andRT
PCR analysis of activinA/EDF OA subunip tmRNA expression in human
monocytes . (A) Left, Northern analysis ofNA subunit mRNA in cultured
monocytes stimulated 4 h with PMA (10 ng/ml), LPS (100 ng/ml),VD3
(10- e M), and their different combinations : middle, same stimulations as
in the left, but for a 24-h incubation period; right, Northern analysis of
OA subunit mRNA in cultured monocytes stimulated 4 h with LPS alone
or in combination with H7 or HA1004 (at 10 and 20 /AM) . Migration
of the 28S and 185 rRNAs is indicated . (B) Autoradiogram of 32P-labeled
nuclear run-off transcripts from nuclei of pmonocytes stimulated for 4 h
with PMA (10 ng/ml) hybridized to a, NA, and ,QB subunit cDNAs in
pGEM-4Z plasmid or plasmid alone bound to nitrocellulose filter. (C)RT
PCR analyses of human (3-actin and (3A subunit mRNAs in monocytes .
The figure shows the 263-bp 0-actin PCR product used as positive con-
trol forRNAintegrity in unstimulated (lane 1) and PMA-stimulated (10
ng/ml ; 4 h ; lane 2) monocytes; absence (lane 3) and presence (lane 4) of
the 786-bp NA PCR product in unstimulated and PMA-stimulated mono-
cytes, respectively; lane S, Pstl digest ofDNA in lane 4 yielding the ex-
pected 508- and 278-bp fragments ; lane 6, HaelII digest of OX174RF
DNA used as molecular weight marker.
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PMA yielded theexpected 786-bp human OA PCR product
(Fig. 1 C), which was identified as identical to previously
described human OA sequences (5, 10) by restriction anal-
ysis (Fig . 1 C) and DNA sequencing (not shown) .
By Western analysis we found that LPS-activated mono-
rytes cultured for 48 h secrete a protein with a molecular
mass -14 kD that upon reduction reacts specifically with
our rabbit no . 560 anti-(3A (93-105) antiserum (Fig. 2) . Its
comigrationwith a rh-activin A/EDF standard further indi-
cates that it represents monoryte-secreted activinA/EDFpro-
tein (Fig. 2) . From these Western analyses, we estimate that
LPS-stimulated monorytes secrete -20-40 ng/ml/106 cells
of activin A/EDF during a48-h culture . We also measured
the activinA/EDF bioactivity ofmonoryte-conditioned media
with the human erythroleukemia K562 cell differentiation
assay (2, 20) . The same concentrated conditioned media that
were positive in Western analysis induced effectively hemo-
globin synthesis in K562 cells (Table 1) . Heat treatmentFigure 2 .
￿
Western analysis of activin A/EDF 13A subunit protein in
human monocyte-conditioned media . (A) Concentrated media conditioned
for 48 hwith unstimulated (lane 1), LPS-stimulated monocytes (lane 2),
and rh-activin A/EDF (10 ng) (lane 3) were run on reducing 15% SDS-
PAGE, and transferred to nitrocellulose filter probed with the no. 560
antiOA(93-105) antipeptide antiserum and 1251-protein A. One lane be-
tween lanes 2 and 3 has been left empty to avoid contamination during
gel loading . (B)A filter identical to that inA probed with the same an-
tiOA(93-105) antipeptide antiserum preabsorbed with the peptide antigen.
The nonspecific binding ofthe antiserum at the 45-50-kD range is prob-
ably due to protein overloading of lanes 1 and2 (human AB serum pro-
teins) . The migration of molecular mass markers is indicated .
markedly increased the bioactivity of the samples, possibly
due to the conversion of latent proactivin A to the mature
active hormone. TheEDF titers ofLPS-stimulated monocyte-
conditioned nontreated and heat-treated mediawere -60 and
-180 EDF U/ml/106 cells, respectively, corresponding to
-20 and -60 ng/ml/10 6 cells of activin A/EDF when com-
pared with the rh-activin A/EDF standard (Table 1) . The
conditioned mediaof nonactivated monocytes also contained
minute amounts of EDF activity (EDF titer, 6 U/ml/106
cells) but only after heat treatment . Although activatedmono-
cytes maysecrete other factors able to induce erythrodifferenti-
ation in K562 cells, ourfindings suggest that activinA/EDF
accounts for most of this activity as the results oftheWestern
and bioassay analyses correlated fairly well .
The ability of human monocyte/macrophages to express
the /3A mRNA and secrete the immunoreactive and bioac-
tive activin A/EDF protein provides insight into the pos-
sible cellular origin of activin A/EDF duringhuman hema-
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The 48-h-conditioned media were tested with and without heat treat-
ment (5 min at 95°C) . The EDF titer (expressed as K562 EDF U/ml)
is defined as the reciprocal of the highest dilution in 1 ml at which differen-
tiation of the K562 cells is still visible compared with complete RPMI
1640 (20) . In our bioassay one K562 EDF U/ml is equal to 0.3 ng/ml
of rh-activin A/EDF, being consistent with previously reported activity
of activins in this assay (2, 20) . We obtained reproducibly -40-45%
differentiation of the target cells with the maximal effective concentra-
tion of rh-activin A/EDF (100 ng/ml) . LPS did not affect K562
hemoglobin synthesis at any concentrations used, nor did the noncondi-
tioned control media . Spontaneous differentiation accounted for only 4-7%
in this assay and is defined as zero EDF U/ml . The data are from three
experiments all giving similar results .
topoiesis. This report andthe recent finding that murine bone
marrow stromal cell lines produce activin A/EDF afterPMA,
TNF, and ILA stimulation (21) suggest that both these cell
types mayplay an important role in thephysiology of activin
A/EDF-regulated hematopoiesis . These two cell types are
likely to contribute to the activin A/EDF bioactivity recently
observed in crude murine bonemarrow cultures (22) . As pe-
ripheral bloodmonocytes mature to tissue macrophages and
scatter throughout most organs of the body, activin A/EDF
may have a wider rangeofbiological effects than we presently
know this versatile differentiation/growth factor has .
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Table 1 . Effects of Monocyte-conditioned






rh-activin A/EDF (0.3 ng/ml) 1 ND
LPS (0.001-10 14g/ml) 0 ND
Unstimulated monocyte medium 0 6
LPS-stimulated monocyte medium 60 180References
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